Regional Medical Director
National Spine and Pain Centers
Rutgers New Jersey Medical School, Newark, NJ
Lincroft, NJ
Sean Li, M.D. specializes in interventional pain management. His clinical interest is in neuromodulation therapy such as spinal cord stimulation, high-frequency stimulation, dorsal root ganglion stimulation and peripheral nerve stimulation. Prior to joining National Spine & Pain Centers, Dr. Li served as the medical director of Premier Pain Centers LLC. In addition to his work at National Spine & Pain Centers, Dr. Li continues to serve as an adjunct associate professor of anesthesiology at Rutgers New Jersey Medical School in Newark, NJ and is an attending physician at Hackensack Meridian Hospitals (Riverview Medical Center in Red Bank, NJ and Jersey Shore University Hospital in Neptune, NJ). Dr. Li earned his medical degree from the State University of New York at Stony Brook and underwent residency training in general surgery at the Mayo Clinic in Rochester, MN and later in anesthesiology at the University of Michigan in Ann Arbor, MI. He completed his fellowship in interventional pain medicine at Johns Hopkins University in Baltimore, MD. Dr. Li is the current president of the New Jersey Society of Interventional Pain Physicians (NJSIPP), Education Committe and Young Neuromodulator Committee member of the International Neuromodulation Society (INS), Director at Large for the American Society of Pain and Neuroscience (ASPN).
Relevant Relationships Disclosed to Learners:
Consulting Fee (e.g., Advisory Board): Abbott, Avanos, Averitas Pharma, Biotronik, Boston Scientific, Nalu Medical, Nevro, PainTeq, Saluda, Scilex Pharma, SPR Therapeutics, Vertos Medical
Contracted Research (Principal Investigators must provide information, even if received by the institution): Avanos, Biotronik, Boston Scientific, Nalu Medical, PainTeq, Saluda, SGX Medical, SPR Therapeutics
Speakers' Bureau: Averitas Pharma, Scilex Pharma
Stock Option Holder (Individual stocks/Stock options; diversified mutual funds do not need to be disclosed): Nalu medical
Disclosure information not submitted.
Friday, September 8, 2023
7:30 AM – 8:20 AM PST
Friday, September 8, 2023
1:40 PM – 2:30 PM PST